New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells

An improved compound of pentagamavunone-1 (PGV-1), chemoprevention-curcumin analog 1.1 (CCA-1.1), has been synthesized and proven to have antiproliferative effects against breast cancer cells. This study is designed to investigate the potency of CCA-1.1 alone and in combination with doxorubicin (Dox...

Full description

Saved in:
Bibliographic Details
Main Authors: Febri Wulandari, Muthi' Ikawati, Dhania Novitasari, Mitsunori Kirihata, Jun-ya Kato, Edy Meiyanto
Format: article
Language:EN
Published: Universitas Gadjah Mada 2020
Subjects:
Online Access:https://doaj.org/article/9b3e16eefe9341d78d2a4662424780b0
Tags: Add Tag
No Tags, Be the first to tag this record!